Abstract:PURPOSE:Neuropathic pain represents a significant public health problem and its effective management remains a challenge. The present study is designed to evaluate the analgesic effect of the spirocyclopiperazinium salt compound DXL-A-24 in spinal nerve ligation (SNL) model, and further to explore the possible molecular mechanisms. METHODS:SNL model was established on rats, and mechanical allodynia and thermal hyperalgesia were estimated with the von Frey and hot plate tests; the expression of CaMKIIα, CREB, JAK2, STAT3 and c-fos was determined by western blotting; the protein level of TNF-α was analysed by ELISA; the mRNA expression of TNF-α and c-fos was detected using qRT-PCR analysis and the receptor blocking test was used for target searching. RESULTS:Administration of DXL-A-24 (1, 0.5, 0.25 mg/kg, i.g.) obviously relieved SNL-induced mechanical allodynia and thermal hyperalgesia in rats (P < 0.01), with the percentage of pain threshold elevation (PTE%) was 103 %, 68 % and 47 %, respectively, in mechanical allodynia; the percentage of maximal possible effect (MPE%) was 56 %, 34 % and 21 %, respectively, in thermal hyperalgesia on day 7 after SNL. Pretreatment with peripheral α7 nicotinic or M4 muscarinic receptor antagonist, the effect of DXL-A-24 was completely blocked (P > 0.05). DXL-A-24 significantly reduced the upregulated pCaMKIIα, pCREB, pJAK2, pSTAT3 and TNF-α protein (P < 0.01), which could be blocked by α7 nicotinic receptor or M4 muscarinic receptor antagonist. In addition, administration of DXL-A-24 attenuated the mRNA and protein expression of c-fos and TNF-α mRNA in DRG of SNL rat. We did not observe significant acute toxicity and chronic hepatorenal impairment at effective dose and high dose. CONCLUSIONS:We report firstly that administration of DXL-A-24 displays obvious antineuropathic pain effects in SNL rats. The underlying mechanism may involve the reduction of the CaMKIIα/CREB and JAK2/STAT3 signalling pathways, and the suppression of TNF-α and c-fos expression, which may be mediated by activating peripheral α7 nicotinic and M4 muscarinic receptors. This study may provide a new perspective for developing new antineuralgic drug.

Substance P(1-7) induces antihyperalgesia in diabetic mice through a mechanism involving the naloxone-sensitive sigma receptors

Substance P Microinjected into the Periaqueductal Gray Matter Induces Antinociception and is Released Following Morphine Administration

Substance P Potentiates Thermal Hyperalgesia Induced by Intrathecal Administration of D-serine in Rats.

Role of Spinal Cholecystokinin Octapeptide, Nociceptin/Orphanin FQ, and Hemokinin-1 in Diabetic Allodynia

The Analgesic Effects of (5R,6R)6-(3-Propylthio-1,2,5-thiadiazol-4-yl)-1-azabicyclo[3.2.1] Octane on a Mouse Model of Neuropathic Pain.

Desensitization to intrathecal substance P in mice: possible involvement of opioids

Impact of N-methylation of the substance P 1-7 amide on anti-allodynic effect in mice after peripheral administration

Substance P Induces Inflammatory Responses Involving NF-κB in Genetically Diabetic Mice Skin Fibroblasts Co-Cultured with Macrophages.

Importance of N- and C-terminal residues of substance P 1-7 for alleviating allodynia in mice after peripheral administration

Substance P Induces Monocyte Chemoattractant Protein-1 Production In Skin Fibroblasts From Genetically-Diabetic Mice Via Activation Of Nf-Kappa B

Alterations in the Substance P-induced Anti-Nociception in the Central Nervous System of Rats after Morphine Tolerance

Retraction Notice to "antinociceptive Effects of Endomorphin-2: Suppression of Substance P Release in the Inflammatory Pain Model Rat".

Antinociceptive Effect of Spirocyclopiperazinium Salt Compound DXL-A-24 and the Underlying Mechanism

From the Anti-Nociceptive Substance P Metabolite Substance P (1-7) to Small Peptidomimetics

Activation of Spinal Glucagon-Like Peptide-1 Receptors Specifically Suppresses Pain Hypersensitivity

Effect and Underlying Mechanisms of Spirocyclopiperazinium Salt Compound DXL-A-24 in Rats Following Spinal Nerve Ligation.

Neurokinin-1 Receptor in Peripheral Nerve Terminals Mediates Thermal Hyperalgesia

Spinal P2X7R Contributes to Streptozotocin-Induced Mechanical Allodynia in Mice

Sigma-1 receptor agonism exacerbates immune-driven nociception: Role of TRPV1 + nociceptors

Effects of sympathetic efferent in diabetic hyperalgesia in rat]

Neuropeptide S Produces Antinociceptive Effects at the Supraspinal Level in Mice